Generate a tailored SOP for Dr. Rohan Katipally. Improve your application with a focused, well-structured draft.
Rohan Katipally, MD, is an Assistant Professor in the Department of Radiation and Cellular Oncology at the University of Chicago. His research focuses on the application of stereotactic body radiotherapy in the treatment of renal cell carcinoma and the use of neoadjuvant chemotherapy in HPV-positive and HPV-negative head and neck cancers. He has contributed to several studies examining the dynamics of circulating tumor HPV-DNA and the role of immune checkpoint inhibitors in cancer therapy. With multiple publications in renowned journals, including JAMA Oncology and Clinical Cancer Research, Dr. Katipally is dedicated to advancing the understanding and treatment of malignancies through innovative therapeutic approaches. He actively engages in clinical trials aimed at improving patient outcomes and exploring new methodologies in oncological treatment.
University of Chicago • Chicago, IL
Teaching and research in the Department of Radiation and Cellular Oncology.
Department of Philosophy